| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 19403593
[patent_doc_number] => 20240287104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/998712
[patent_app_country] => US
[patent_app_date] => 2021-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998712
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998712 | NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY | Dec 4, 2021 | Pending |
Array
(
[id] => 20218723
[patent_doc_number] => 20250281654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => METHODS FOR TREATING CANCER USING COMBINATIONS OF EPIGENETIC THERAPIES AND RADIOCONJUGATE TARGETING AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/036723
[patent_app_country] => US
[patent_app_date] => 2021-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9250
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18036723
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/036723 | METHODS FOR TREATING CANCER USING COMBINATIONS OF EPIGENETIC THERAPIES AND RADIOCONJUGATE TARGETING AGENTS | Nov 25, 2021 | Pending |
Array
(
[id] => 18365876
[patent_doc_number] => 20230147467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => Novel Contrast Agents and Imaging Methods for Early Detection of Diseases
[patent_app_type] => utility
[patent_app_number] => 17/523911
[patent_app_country] => US
[patent_app_date] => 2021-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17523911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/523911 | Novel Contrast Agents and Imaging Methods for Early Detection of Diseases | Nov 10, 2021 | Abandoned |
Array
(
[id] => 17719161
[patent_doc_number] => 20220211880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => IMAGING WITH LIPOSOME-BASED CONTRAST AGENTS BASED ON MODULATION OF MEMBRANE WATER PERMEABILITY
[patent_app_type] => utility
[patent_app_number] => 17/520133
[patent_app_country] => US
[patent_app_date] => 2021-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17520133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/520133 | IMAGING WITH LIPOSOME-BASED CONTRAST AGENTS BASED ON MODULATION OF MEMBRANE WATER PERMEABILITY | Nov 4, 2021 | Abandoned |
Array
(
[id] => 18700125
[patent_doc_number] => 11786613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Magnetic tracer compositions
[patent_app_type] => utility
[patent_app_number] => 17/497119
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 17
[patent_no_of_words] => 20632
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497119
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/497119 | Magnetic tracer compositions | Oct 7, 2021 | Issued |
Array
(
[id] => 18628354
[patent_doc_number] => 20230287217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => Zwitterionic Cell-Permeant and Water-Soluble Rhodamine Dyes for Quantitative Imaging Applications
[patent_app_type] => utility
[patent_app_number] => 18/248045
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 363
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248045
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248045 | Zwitterionic Cell-Permeant and Water-Soluble Rhodamine Dyes for Quantitative Imaging Applications | Oct 5, 2021 | Pending |
Array
(
[id] => 18784871
[patent_doc_number] => 20230372552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => CONJUGATE OR ITS SALT COMPRISING A GASTRIN-RELEASING PEPTIDE RECEPTOR ANTAGONIST AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/246706
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246706
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246706 | CONJUGATE OR ITS SALT COMPRISING A GASTRIN-RELEASING PEPTIDE RECEPTOR ANTAGONIST AND USES THEREOF | Sep 21, 2021 | Pending |
Array
(
[id] => 18738076
[patent_doc_number] => 20230346989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => FLUOROCARBON NANOEMULSIONS AND USES THEREOF IN IMAGING
[patent_app_type] => utility
[patent_app_number] => 18/026759
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23905
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026759
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/026759 | FLUOROCARBON NANOEMULSIONS AND USES THEREOF IN IMAGING | Sep 16, 2021 | Pending |
Array
(
[id] => 18656266
[patent_doc_number] => 20230302160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => TUMOR CONTRAST COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN TUMOR DIAGNOSTIC IMAGING
[patent_app_type] => utility
[patent_app_number] => 18/023526
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023526
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023526 | TUMOR CONTRAST COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN TUMOR DIAGNOSTIC IMAGING | Aug 25, 2021 | Pending |
Array
(
[id] => 18739456
[patent_doc_number] => 20230348378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => SMALL MOLECULE ALBUMIN BINDERS
[patent_app_type] => utility
[patent_app_number] => 18/042209
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -86
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042209
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042209 | SMALL MOLECULE ALBUMIN BINDERS | Aug 19, 2021 | Pending |
Array
(
[id] => 18673153
[patent_doc_number] => 20230310643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS
[patent_app_type] => utility
[patent_app_number] => 18/041827
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041827
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041827 | EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS | Aug 17, 2021 | Pending |
Array
(
[id] => 17368393
[patent_doc_number] => 20220023445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/403058
[patent_app_country] => US
[patent_app_date] => 2021-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17403058
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/403058 | TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION | Aug 15, 2021 | Abandoned |
Array
(
[id] => 20348617
[patent_doc_number] => 20250345469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-13
[patent_title] => COMPOSITION COMPRISING A RAPALOG AND A RADIOLABELLED GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN THE TREATMENT AND/OR DIAGNOSIS OF CCKB RECEPTOR POSITIVE CANCER OR TUMORS
[patent_app_type] => utility
[patent_app_number] => 18/040011
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040011
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040011 | COMPOSITION COMPRISING A RAPALOG AND A RADIOLABELLED GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN THE TREATMENT AND/OR DIAGNOSIS OF CCKB RECEPTOR POSITIVE CANCER OR TUMORS | Jul 29, 2021 | Pending |
Array
(
[id] => 18597475
[patent_doc_number] => 20230272271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => Protected Quantum Dots for Therapeutic, Diagnostic, and Other Uses
[patent_app_type] => utility
[patent_app_number] => 18/017872
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 299
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017872
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017872 | Protected Quantum Dots for Therapeutic, Diagnostic, and Other Uses | Jul 27, 2021 | Abandoned |
Array
(
[id] => 18673167
[patent_doc_number] => 20230310660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => SHELF-STABLE INDOCYANINE GREEN SOLUTIONS AND METHODS OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/007392
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007392
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007392 | SHELF-STABLE INDOCYANINE GREEN SOLUTIONS AND METHODS OF MAKING THE SAME | Jul 27, 2021 | Abandoned |
Array
(
[id] => 17503562
[patent_doc_number] => 20220096664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS
[patent_app_type] => utility
[patent_app_number] => 17/369727
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17369727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/369727 | STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS | Jul 6, 2021 | Pending |
Array
(
[id] => 17369852
[patent_doc_number] => 20220024904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => REAGENT FOR BIOCONJUGATION VIA IRREVERSIBLE REBRIDGING OF DISULFIDE LINKAGES
[patent_app_type] => utility
[patent_app_number] => 17/368272
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368272 | REAGENT FOR BIOCONJUGATION VIA IRREVERSIBLE REBRIDGING OF DISULFIDE LINKAGES | Jul 5, 2021 | Abandoned |
Array
(
[id] => 19396183
[patent_doc_number] => 12070512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-27
[patent_title] => Targeted gas-filled microvesicles formulation
[patent_app_type] => utility
[patent_app_number] => 17/352773
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8852
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17352773
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/352773 | Targeted gas-filled microvesicles formulation | Jun 20, 2021 | Issued |
Array
(
[id] => 18724431
[patent_doc_number] => 20230338590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => MATERIALS AND METHODS FOR TREATING CORONAVIRUS
[patent_app_type] => utility
[patent_app_number] => 18/010510
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010510
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/010510 | MATERIALS AND METHODS FOR TREATING CORONAVIRUS | Jun 14, 2021 | Pending |
Array
(
[id] => 18467099
[patent_doc_number] => 20230201380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/927917
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927917
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/927917 | NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGING | May 25, 2021 | Pending |